marginal significanceP = 0.0667
By percentage comparison, we identified a larger percentage of CD63/81+ sEVs in enucleated AH with marginal significance (22.5 ± 11.3%, enucleated versus 7.10 ± 1.41%, salvaged, P = 0.0667; see Fig. 4 E).
By percentage comparison, we identified a larger percentage of CD63/81+ sEVs in enucleated AH with marginal significance (22.5 ± 11.3%, enucleated versus 7.10 ± 1.41%, salvaged, P = 0.0667; see Fig. 4 E).